 | Exelixis (EXEL) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - February 18 at 1:28 AM |
| Michael Morrissey Sells 25,000 Shares of Exelixis, Inc. (NASDAQ:EXEL) Stock
www.americanbankingnews.com - February 17 at 4:16 AM |
| Exelixis, Inc. (NASDAQ:EXEL) Director Alan M. Garber Sells 12,500 Shares
www.americanbankingnews.com - February 17 at 4:16 AM |
| Exelixis (NASDAQ:EXEL) Stock Rating Reaffirmed by William Blair
www.americanbankingnews.com - February 14 at 4:34 PM |
| Exelixis, Inc. Expected to Earn FY2022 Earnings of $1.96 Per Share (NASDAQ:EXEL)
www.americanbankingnews.com - February 14 at 12:43 PM |
 | Exelixis to Release Fourth Quarter and Full Year 2019 Financial Results on Tuesday, February 25, 2020 - Yahoo Finance
finance.yahoo.com - February 13 at 2:45 PM |
| Exelixis, Inc. (NASDAQ:EXEL) Director Sells $80,560.00 in Stock
www.americanbankingnews.com - February 13 at 4:26 AM |
| Exelixis to Release Fourth Quarter and Full Year 2019 Financial Results on Tuesday, February 25, 2020
finance.yahoo.com - February 12 at 5:39 PM |
| Exelixis (NASDAQ:EXEL) Earns "Buy" Rating from Piper Sandler
www.americanbankingnews.com - February 12 at 6:59 AM |
| Exelixis, Inc. (NASDAQ:EXEL) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 12 at 6:59 AM |
| Exelixis (EXEL) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
finance.yahoo.com - February 12 at 12:48 AM |
 | Exelixis Reports Positive Results in Metastatic Castration-Resistant Prostate Cancer Study - Motley Fool
www.fool.com - February 12 at 12:48 AM |
 | Exelixis (EXEL) Outpaces Stock Market Gains: What You Should Know - Nasdaq
www.nasdaq.com - February 11 at 7:47 PM |
| Exelixis (EXEL) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - February 11 at 7:47 PM |
 | Exelixis (EXEL) PT Raised to $35 at SunTrust Following Strong KOL Feedback - StreetInsider.com
www.streetinsider.com - February 11 at 2:46 PM |
 | Exelixis' cabozantinib combo shows encouraging action in prostate cancer - Seeking Alpha
seekingalpha.com - February 11 at 9:29 AM |
| Exelixis (EXEL) Announces Encouraging Results for Cabozantinib in Combination With Atezolizumab in Metastatic CRPC - StreetInsider.com
www.streetinsider.com - February 10 at 5:57 PM |
| Exelixis Announces Encouraging Results for Cabozantinib in Combination With Atezolizumab in Metastatic Castration-Resistant Prostate Cancer
finance.yahoo.com - February 10 at 5:57 PM |
| Exelixis, Inc. (NASDAQ:EXEL) CMO Gisela Schwab Sells 50,000 Shares
www.americanbankingnews.com - February 10 at 4:23 AM |
| $240.92 Million in Sales Expected for Exelixis, Inc. (NASDAQ:EXEL) This Quarter
www.americanbankingnews.com - February 9 at 3:50 AM |
| Analysts Anticipate Exelixis, Inc. (NASDAQ:EXEL) to Post $0.15 EPS
www.americanbankingnews.com - February 7 at 10:57 AM |
 | Exelixis Announces Webcasts of Investor Conference Presentations in February - Business Wire
www.businesswire.com - February 6 at 10:21 PM |
| Exelixis (EXEL) Gains But Lags Market: What You Should Know - Yahoo Finance
finance.yahoo.com - February 4 at 11:07 PM |
| Exelixis (EXEL) Gains But Lags Market: What You Should Know
finance.yahoo.com - February 4 at 11:06 PM |
| Exelixis, Inc. (NASDAQ:EXEL) CEO Michael Morrissey Sells 25,000 Shares
www.americanbankingnews.com - January 31 at 10:30 PM |
| Exelixis Announces Partner Takeda Files New Drug Application in Japan for CABOMETYX® (cabozantinib) for Advanced Hepatocellular Carcinoma - Yahoo Finance
finance.yahoo.com - January 29 at 8:43 AM |
| Exelixis Announces Partner Takeda Files New Drug Application in Japan for CABOMETYX® (cabozantinib) for Advanced Hepatocellular Carcinoma
www.businesswire.com - January 29 at 4:31 AM |
| Exelixis, Inc. (NASDAQ:EXEL) Short Interest Update
www.americanbankingnews.com - January 28 at 5:20 PM |
 | With Abbott, Exelixis and Penumbra expanding, Alameda (again) is a biotech hotspot - San Francisco Business Times - San Francisco Business Times
www.bizjournals.com - January 28 at 2:15 PM |
| Needham & Company LLC Reiterates Buy Rating for Exelixis (NASDAQ:EXEL)
www.americanbankingnews.com - January 27 at 2:16 PM |
| Roche Submits Application for Tecentriq-Avastin Combo in HCC
finance.yahoo.com - January 27 at 1:03 PM |
| Exelixis up 1% premarket on Cabometyx data in liver cancer - Seeking Alpha
seekingalpha.com - January 24 at 8:13 AM |
| Exelixis Announces Results for Combination of Cabozantinib and Nivolumab With or Without Ipilimumab in Advanced Hepatocellular Carcinoma
finance.yahoo.com - January 24 at 8:13 AM |
| Exelixis: Looking Good, Despite Stagnant Product Sales Guidance - Seeking Alpha
seekingalpha.com - January 23 at 1:22 AM |
| Can Investors Excel in 2020 With Exelixis? - Motley Fool
www.fool.com - January 22 at 3:22 PM |
| Can Investors Excel in 2020 With Exelixis?
www.fool.com - January 22 at 2:42 PM |
| How this East Bay biotech went from debt to expansion
finance.yahoo.com - January 21 at 11:26 PM |
| How Exelixis went from debt to expansion - San Francisco Business Times - San Francisco Business Times
www.bizjournals.com - January 21 at 6:25 PM |
| Exelixis: What's Ahead For 2020 - Seeking Alpha
seekingalpha.com - January 19 at 8:50 AM |
| Exelixis: What's Ahead For 2020
seekingalpha.com - January 19 at 5:15 AM |
| GILD or EXEL: Which Is the Better Value Stock Right Now? - Yahoo Finance
finance.yahoo.com - January 18 at 1:42 AM |
| GILD or EXEL: Which Is the Better Value Stock Right Now?
finance.yahoo.com - January 17 at 3:41 PM |
| Exelixis, Inc. (EXEL) CEO Michael Morrissey on 38th Annual JPMorgan Healthcare Conference (Transcript) - Seeking Alpha
seekingalpha.com - January 15 at 2:26 AM |
| Does Exelixis, Inc. (NASDAQ:EXEL) Have A Good P/E Ratio? - Yahoo Finance
finance.yahoo.com - January 14 at 4:25 PM |
| Does Exelixis, Inc. (NASDAQ:EXEL) Have A Good P/E Ratio?
finance.yahoo.com - January 14 at 4:25 PM |
| Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
finance.yahoo.com - January 13 at 4:35 PM |
| Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?
finance.yahoo.com - January 13 at 4:35 PM |
| UPDATE: SunTrust Starts Exelixis (EXEL) at Buy - StreetInsider.com
www.streetinsider.com - January 13 at 6:54 AM |
| Exelixis sees $245M in Q4 revenues - Seeking Alpha
seekingalpha.com - January 12 at 8:53 PM |
| Exelixis Outlines Key Priorities and Anticipated Milestones for 2020-21, Announces Preliminary Fourth Quarter and Full Year 2019 Financial Results, and Provides 2020 Financial Guidance
finance.yahoo.com - January 12 at 8:53 PM |
